The insurer Cigna on Thursday said the company would ** longer cover the full-price EpiPen, which costs as much as $600. Those prices sparked outrage last summer when customers with high-deductible healthcare plans were caught off guard by the high prices for a once-reasonable healthcare need. The pharmaceutical company Mylan bought the rights to the EpiPen in 2007 and systematically raised the allergy tool's prices over the following nine years.* Read more...